Menu
KrASIA
News

CHINA BRIEF | Tencent-backed online medical unicorn Miaoshou Doctor closes USD 85 million Series D1 round

Written by Song Jingli Published on 

Share
New funds will be used to develop Miaoshou’s online services and insurance business.

Beijing Yuanxin Technology, also known as Miaoshou Doctor, has raised RMB 600 million (USD 85 million) in a Series D1 round, joined by Qiming Venture Partners, INCE Capital, Sequoia Capital China, Citic Securities, and Index Capital, according to a post on the official WeChat account of Qiming on Monday.

The new funds will be used to develop Miaoshou’s online services and insurance business.

Miaoshou Doctor manages an app that allows individuals to consult doctors via videos or telephone calls, allowing customers to also buy medicine and health insurance plans.

The investment round comes one year after Miaoshou raised an undisclosed amount on its Series C3 round, where it increased its valuation to RMB 7 billion (USD 1.01 billion). In 2018, Tencent led the firm’s RMB 500 million Series C round, with the participation of Sequoia Capital China.

This article is part of KrASIA’s “China Brief” section, where KrASIA’s reporters will provide quick daily updates about the tech ecosystem in China.

Share

You might like these

  • Insights

    Blind man regains sight after receiving first artificial cornea implant by Israel’s CorNeat Vision

    By 

    NoCamels

    19 Jan 2021    11:35 AM

KrASIA InsightsKrASIA Insights

  • Beijing-based SaaS firm Aibee digitizes “space, people, and products” for brick-and-mortar retailers.

    Insights

    This firm digitizes offline shopping: Inside China’s Startups 

    By Wency Chen

    23 Jan 202101:05 AM

Most PopularMost Popular

See All